2011
DOI: 10.1007/s00018-011-0718-2
|View full text |Cite
|
Sign up to set email alerts
|

Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action

Abstract: Due to the rapid emergence of resistant microbes to the currently available antibiotics, cationic antimicrobial peptides have attracted considerable interest as a possible new generation of anti-infective compounds. However, low cost development for therapeutic or industrial purposes requires, among other properties, that the peptides will be small and with simple structure. Therefore, considerable research has been devoted to optimizing peptide length combined with a simple design. This review focuses on the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
141
1
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 141 publications
(149 citation statements)
references
References 162 publications
6
141
1
1
Order By: Relevance
“…Despite toxicity, in 2003 a member of this family, daptomycin, which is active only toward Gram-positive bacteria, has been approved by the FDA in an injection formulation for the treatment of complicated skin and skin structure infections (SSSI) caused by susceptible strains of the following species: S. aureus (including methicillin-resistant strains), Streptococcus pyogenes, S. agalactiae, S. dysgalactiae subspecies equisimilis, and Enterococcus faecalis (vancomycin-susceptible strains only). This example confirms the growing opinion that peptide-based antibiotics will be among the next generation of antiinfective therapy (Mangoni & Shai, 2011). Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides active against multidrug-resistant Gram-positive pathogens (Zhanel et al, 2010).…”
Section: Lipopeptides and Lipoglycopeptidessupporting
confidence: 69%
See 3 more Smart Citations
“…Despite toxicity, in 2003 a member of this family, daptomycin, which is active only toward Gram-positive bacteria, has been approved by the FDA in an injection formulation for the treatment of complicated skin and skin structure infections (SSSI) caused by susceptible strains of the following species: S. aureus (including methicillin-resistant strains), Streptococcus pyogenes, S. agalactiae, S. dysgalactiae subspecies equisimilis, and Enterococcus faecalis (vancomycin-susceptible strains only). This example confirms the growing opinion that peptide-based antibiotics will be among the next generation of antiinfective therapy (Mangoni & Shai, 2011). Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides active against multidrug-resistant Gram-positive pathogens (Zhanel et al, 2010).…”
Section: Lipopeptides and Lipoglycopeptidessupporting
confidence: 69%
“…These HDPs are produced by dermal glands, stored within granules and released on the skin surface upon stress, injury, or electrical or norepinephrine stimulation. Their synthesis is induced by contact with microorganisms and is transcriptionally regulated by the NF-jB/IjBa machinery (Mangoni & Shai, 2011). These peptides constitute a rich arsenal of broad-spectrum, cytolytic AMPs characterized by highly variable sequences (Vanhoye et al, 2003).…”
Section: Amphibian Host Defense Peptidesmentioning
confidence: 99%
See 2 more Smart Citations
“…AMPs are ubiquitous elements of the innate immune response in a variety of organisms, and most of them included in different databases 6 . They are generally comprising from 10-50 amino acids, and share a cationic character due to prevalence of basic residues, and an amphipathic structure in membrane -mimicking environments 7 .…”
Section: Introductionmentioning
confidence: 99%